July 27, 2022
Via: MedTech DiveBoston Scientific weathered ongoing COVID-19 and macroeconomic pressures in the second quarter, leading the company to raise its 2022 forecast for organic revenue growth. CEO Michael Mahoney said on a Wednesday earnings call that the company now expects more “durable […]
July 9, 2024
June 25, 2024